Thérèse Aurran

Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial

Stéphane Leprêtre, Thérèse Aurran, Beatrice Mahé et al. · Blood · 2012 · 92 citations · Full text

Medicine, Oncology, Pharmacology +14

High incidence of atrial fibrillation in patients treated with ibrutinib

Florian Baptiste, Jennifer Cautela, Yan Ancedy et al. · Open Heart · 2019 · 70 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia

Christian Buske, Meletios Α. Dimopoulos, Alexander Grunenberg et al. · Journal of Clinical Oncology · 2023 · 41 citations

Medicine, Oncology, Pharmacology +14

Patients’ Non-Medical Characteristics Contribute to Collective Medical Decision-Making at Multidisciplinary Oncological Team Meetings

Léa Restivo, Thémis Apostolidis, Anne‐Déborah Bouhnik et al. · PLoS ONE · 2016 · 35 citations · Full text

Management, Oncology, Decision Making +16

Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort

Florian Bouclet, Anne Calleja, Marie‐Sarah Dilhuydy et al. · Annals of Hematology · 2021 · 32 citations

Medicine, Hematology, Oncology +6